Clinical Diagnostics and Research Tools

  1. 26 Mar 2021  |  North America  |  Customer Research

    Global Laboratory Product Purchasing Trends, 2020–2021

    An End-user Perspective on Laboratory Spending Reveals Modest 2021 Budget Increases Following Healthier 2020 Spending

    Readers of one of Frost & Sullivan’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021. Frost & Sullivan has conducted similar studies among the same targeted respondents since 2012. Where applicable, the study presents yea...


    Special Price $3,712.50 save 25 %

  2. 23 Feb 2021  |  North America  |  Market Research

    AI-Based Image Analysis Tools and Cloud-Based Deployment to Expand the Global Digital Pathology Market

    Increased Demand for Remote Pathology Services and Centralization of Digital Pathology Workflow in Hospital Networks to Spark New Growth Opportunities

    The Transformational Health team at Frost & Sullivan provides critical insights into the global digital pathology market, highlighting key growth opportunities, market revenue forecast, and business models that will play an essential role in its growth. The study segments the market by product (hardware, software, and storage solutions) and region ...


    Special Price $3,712.50 save 25 %

  3. 16 Feb 2021  |  North America  |  Market Research

    Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market

    Mobility Ecosystem Holds Bold Promise to Expand Patients’ Access to Care

    Smartphone-based devices and associated tools are becoming the ideal next-generation point-of-care testing (POCT) solutions for in vitro diagnostics. The global COVID-19 pandemic has led to frugal innovations in POCT. The World Health Organization (WHO) has endorsed POCT as the topmost research priority in response to the COVID-19 outbreak. Digital...


    Special Price $1,837.50 save 25 %

  4. 03 Feb 2021  |  North America  |  Market Research

    Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

    Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

    2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...


    Special Price $3,712.50 save 25 %

  5. 11 Dec 2020  |  North America  |  Market Research

    COVID-19 Pandemic Catalyzes the Transformation of the In-vitro Diagnostics Industry

    Future Growth Potential is Enriched by Alternate Testing Sites in the Point-of-Care Testing Segment

    This research service provides critical insights into the impact of COVID-19 on the global in-vitro diagnostics (IVD) industry, highlighting the growth opportunities, market revenue, and technology trends that influence its growth. Its three major segments identify the strategic imperatives of the IVD industry, the impact of COVID-19 on the IVD gro...


    Special Price $1,837.50 save 25 %

  6. 11 Dec 2020  |  North America  |  Market Research

    Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020

    Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity

    The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...


    Special Price $1,837.50 save 25 %

  7. 03 Nov 2020  |  North America  |  Frost Radar

    Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020

    A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines

    Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...


    Special Price $3,712.50 save 25 %

  8. 14 Sep 2020  |  North America  |  Market Research

    Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024

    COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth

    The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathog...


    Special Price $3,712.50 save 25 %

  9. 27 Aug 2020  |  Global  |  Market Research

    Smart Labs as Key Drivers for the Digital Transformation of Diagnostic Laboratories, 2020

    Robotic Automation, Internet of Things (IoT), and Artificial Intelligence (AI) Offering Growth Opportunities for Academic and Commercial Diagnostics Labs

    Diagnostic academic and commercial research labs suffer from cost pressures, given the ongoing Protecting Access to Medicare Act (PAMA) regulations and reproducibility issues, and are under productivity strain. The recent COVID-19 pandemic leading to increasing test volumes and renewed focus on research and development (R&D) to drive innovation wil...


    Special Price $2,250.00 save 25 %

  10. 05 May 2020  |  North America  |  Frost Radar

    FROST RADAR™: Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry, 2020

    Benchmarking Future Growth Potential

    Pharmaceutical drug discovery and development suffers from declining success rates with new molecules and the rate of return shrinking from 16Percentage in 2011 to almost 11Percentage in 2018. Frost & Sullivan research indicates that traditional solutions that have focused primarily on data from limited sources and rule-based computational techniqu...


    Special Price $3,712.50 save 25 %